Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia
- PMID: 11593
Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia
Similar articles
-
Allogeneic marrow transplantation using matched sibling donors.Transplant Proc. 1974 Dec;6(4 Suppl 1):115-9. Transplant Proc. 1974. PMID: 4155158 Review. No abstract available.
-
[Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].Ned Tijdschr Geneeskd. 1978 Mar 11;122(10):326-32. Ned Tijdschr Geneeskd. 1978. PMID: 24811 Dutch. No abstract available.
-
Immunosuppression for clinical marrow transplantation.Semin Hematol. 1974 Jul;11(3):341-51. Semin Hematol. 1974. PMID: 4151847 Review. No abstract available.
-
[Transplantation of bone marrow in aplastic anemia and leukemias (author's transl)].Haematologica. 1979 Oct;64 Suppl:239-48. Haematologica. 1979. PMID: 44252 Review. Italian. No abstract available.
-
Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.Transplant Proc. 1976 Dec;8(4):595-602. Transplant Proc. 1976. PMID: 136773
Cited by
-
Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.Br Med J (Clin Res Ed). 1981 Mar 14;282(6267):860-3. doi: 10.1136/bmj.282.6267.860. Br Med J (Clin Res Ed). 1981. PMID: 6783204 Free PMC article.
-
Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment.Front Oncol. 2018 Dec 5;8:587. doi: 10.3389/fonc.2018.00587. eCollection 2018. Front Oncol. 2018. PMID: 30568919 Free PMC article. Review.
-
Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.Blut. 1980 Sep;41(3):151-245. doi: 10.1007/BF02464145. Blut. 1980. PMID: 7000209 No abstract available.